The Journal of Neuroscience, August 1994, 74(E): 49274936

The Role of Endogenous in a Poststimulation Increase in the Acetylcholine Content of a Sympathetic Ganglion

A. Tandon and B. Collier Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada

Previous experiments showed that exposure of sympathetic crease of ganglionic ACh that is available for subsequent ganglia to exogenous adenosine increased acetylcholine mobilization and release. (ACh) content and its subsequent release. This effect was [Key words: adenosine, ACh, synaptic potentiation, nucle- not mediated through extracellular adenosine receptors, but oside transport, , superior cervical ganglion] at an intracellular site following its uptake through nitroben- zylthioinosine (NBTI)-resistant transporters. We In a recent article, we reported that adenosinecan, under par- postulated that endogenous adenosine may play a role in ticular experimental conditions, increasethe acetylcholine(ACh) modulating synaptic transmission in the superior cervical content of superior cervical ganglia(Tandon and Collier, 1993). ganglion. The present study tested whether adenosine is This effect was manifest when adenosinewas perfused through involved in the activation of ACh synthesis that occurs during a ganglion at rest; it appeared not to result from an action of a rest period following prolonged presynaptic tetanic activ- adenosineon the classicalextracellular adenosinereceptors in ity. Conditioning of ganglia with high-frequency stimulation that it was not blocked by adenosinereceptor antagonists,but (15 Hz) for 45 min followed by a 15 min rest increased their it was prevented by agents like dipyridamole that block aden- ACh content by 45%. The appearance of this “rebound ACh” osine uptake. These properties clearly distinguish the effect of showed sensitivity to nucleoside transport inhibitors; it was adenosineto increaseACh stores from its well-studied effect to prevented by dipyridamole, but not by NBTI or meclonaze- decreasetransmitter release(see review by White, 1988); the pam, and it was reduced in the presence of RO 1 l-3624, latter effect isonly manifest during stimulation, and it isblocked suggesting an involvement of NBTI-resistant transporters. by antagonists. The effect of dipyridamole was specific for the synthesis of We showed in that initial report that the extra ACh synthe- rebound ACh in that it did not inhibit ACh release or ACh sized in adenosine’spresence was releasableafter adenosine’s synthesis during stimulation. The inhibitory action of dipyr- removal, but, otherwise, its potential physiologic significance idamole on the synthesis of rebound ACh was not evident wasnot explored. The presentwork attempted to do so by testing if it was present only during the tetanic stimulation but it was if the adenosinephenomenon is related to a well-reported ex- if dipyridamole was present during the rest period following ample of presynaptic adaption that is reflected as an increasein it, suggesting that adenosine’s presence after tetanic stim- the ACh content of a sympathetic ganglion following a condi- ulation is of importance. This conclusion was strengthened tioning paradigm of high-frequency long-duration stimulation by experiments showing that the presence of cyclopentyl- of its preganglionic input. , an antagonist at inhibitory adenosine recep- This poststimulation increasein ACh storeswas first reported tors, increased ACh output evoked by test stimulation im- by Rosenblueth et al. (1939) and has been described subse- mediately following tetanic activity, as if endogenous quently in greater detail by Freisen and Khatter (1971) Birks adenosine was available at that time to activate the aden- and Fitch (1974) Bourdois et al. (1974) O’Regan and Collier osine receptors that inhibit transmitter release. ACh release (198 l), and Collier et al. (1983). It resultsfrom an accelerated from conditioned ganglia was 44%. greater than that from rate of ACh synthesis,possibly due to increasedcholine uptake the controls. However, the rebound ACh was not mobilized (O’Regan and Collier, 198 1; Collier et al., 1983) during a period in the presence of 2-(4-phenylpiperidino)cyclohexanol (ve- of rest that follows the conditioning stimulation, and can in- samicol), a vesicular ACh transporter inhibitor. These results creasetissue ACh by up to 70%, depending upon the frequency suggest that endogenous adenosine released after tetanic and duration of the conditioning stimuli. The extra transmitter, stimulation activates ACh synthesis, which results in an in- which we will refer to as “rebound ACh,” is incorporated into a releasablepool (Bourdois et al., 1974; Birks, 1977; Collier et al., 1983) but there is some uncertainty about the particular intraterminal‘store that is augmentedby the extra ACh synthe- sized. Although it is not clear that rebound ACh is formed under Received Nov. 29, 1993; revised Feb. 3, 1994; accepted Feb. 16, 1994. We thank Ms. Anna McNicoll for her excellent technical assistance. A.T. re- physiological conditions, other patterns of neuronal activity, ceived a studentship from the Faculty of Medicine of McGill University. This which may occur in viva, promote its formation; Birks (1978) work was supported by a grant from the Medical Research Council of Canada. reported that short repetitive bursts of high-frequency pulses Correspondence should be addressed to Anurag Tandon, Department ofPhar- macology and Therapeutics, McGill University, 3665 Drummond Street, Mon- could increase ACh content even though the same mean fre- treal, Quebec, Canada, H3G IY6. quency, when applied in evenly spacedpulses, did not. In ad- Copyright 0 1994 Society for Neuroscience 0270-6474/94/144927-10$05.00/O dition, experimental hypoxia produced a phenomenon similar 4929 Tandon and Collier * Adenosine Increases ACh Synthesis after Tetanic Activity

to rebound ACh (Birks, 1978); this effect resulted from an in- square wave pulses (8-10 V, 0.5 msec, 5 or 15 Hz) using a platinum creased discharge rate of preganglionic neurons because it was electrode. During periods of prolonged stimulation, the electrode was moved a few millimeters proximally along the nerve every 10 min. not evident ifthe cervical sympathetic trunk was first transected. When measuring ACh release, the perfusate was collected in 2 or 5 min The mechanism by which the synthesis of rebound ACh is periods into prechilled tubes and stored on ice for not more than 1 hr. initiated remains to be elucidated; transmitter release during Samples were stored overnight at -20°C for assay the following day. the tetanic conditioning is necessary for its induction (Collier Measurementof ACh. ACh was obtained from the aqueous tissue et al., 1983) but the phenomenon appears not to require ACh extracts and the perfusate samples by the method of Fonnum (1969) as described by Welner and Collier (1984). Briefly, the samples were action on muscarinic (Bourdois et al., 1974) or nicotinic (Collier extracted by 400 ~1 of tetraphenylboron in butyronitrile (TPB/butyron- et al., 1983) receptors. These observations suggest the possibility itrile; 10 mgml). The choline esters were removed from the organic that some releasable factor other than ACh might be involved phase by 150 ~1 of AgNO, (20 mgml); excess silver was precipitated in initiating the synthesis ofrebound ACh. As mentioned above, with 10 ~1 of MgCl, (1 M). Samples were lyophilized to dryness. The ACh content of the samples was determined according to the adenosine can increase ganglionic ACh content, and thus sug- radioenzymatic method of Goldberg and McCaman (1973). Choline gested itself as a candidate for this putative factor that mediates was phosphorylated by choline kinase and ATP. ACh was hydrolyzed the formation of the rebound ACh, and the aim of the present to choline with acetylcholinesterase and phosphorylated with y-“P- study was to test this idea. To do so, we tested if the drugs that ATP. The phosphorylated choline was separated from the labeled ATP prevented the adenosine-induced increase in transmitter content by anion-exchange chromatography and the radioactivity measured by liquid scintillation spectrometry. UP was measured in 10 ml ofOptiPhase could also affect the accumulation of rebound ACh. If the two HiSafe II with an counting efficiency of 99%. phenomena are related, they should have a similar pharmaco- Statisticalanal.vsis. Statistical comparisons were done using two-tailed logical sensitivity to nucleoside transport inhibitors. A second Student’s t test for paired samples. This analysis was appropriate for all related objective of this work was to examine the relationship comparisons between the two ganglia of each animal: one was used as the test preparation and its contralateral served as control. The values between rebound ACh and the releasable ACh compartments are presented as percentage or amount of change; each such value was in order to clarify the uncertainty mentioned above. calculated for each pair of ganglia. To evaluate differences between Some of this work has been presented in abstract form (Tan- unpaired conditions, ANOVA and Newman-Keuls for the post hoc don and Collier, 199 1). comparison were used. Results Materials and Methods Efect of nucleosidetransport inhibitors on the accumulation of Muter;& used. r-“P-ATP (IO Ci/mmol) was purchased from New rebound ACh England Nuclear (Boston, MA); butyronitrile was obtained from Aldrich Nucleoside transporters are classified into two groups on the Chemical Co. (Milwaukee. WI):II OotiPhase. HiSafe II was from LKB: acetylcholine chloride was from Hoffmann-LaRoche (Basel, Switzer- basisof their sensitivity to inhibition by nitrobenzylthioinosine land); Meclonazepam and RO 1 l-3624 were generous gifts from Hoff- (NBTI), that is, NBTI-sensitive or NBTI-resistant nucleoside mann-LaRoche (Mississauga, Canada); EGTA was obtained from East- transporters; both types are blocked by dipyridamole. The initial man Kodak (Rochester, NY ); cyclohexyladenosine and cyclopentyltheophylline were from Research Biochemicals Inc. (Natick, experiments tested whether the synthesis of rebound ACh is MA); Amberlite CG-400 (chloride form), choline chloride, dipyrida- altered by the presenceof nucleoside transport inhibitors. In mole, nitrobenzylthioinosine, tetraphenylboron (sodium salt), a-chlor- thesetests, the ACh content ofthe contralateral ganglion, neither alose, acetylcholinesterase (EC 3.1.1.7, ACh hydrolase, type V-S), cho- stimulated nor exposed to the nucleoside transport inhibitors, line kinase (EC 2.7.1.32, ATP:choline phosphotransferase), and physostigmine sulfate were all purchased from Sigma Chemical Co. (St. allowed usto estimatethe initial ACh content ofthe test ganglion Louis, MO). Vesamicol was a gift of Dr. S. M. Parsons (University of since the amount of transmitter contained in both superior cer- California at Santa Barbara) or was synthesized by Dr. T. H. Chan vical ganglia is normally the same (Feldberg, 1943; Birks and (McGill Universitv) bv reacting: 4-uhenvlpineridine (a aift of Dr. M. Macintosh, 1961). The test ganglia were subjected to pregan- Peel, Glaxo) with cyclohexene oxide. AI1 other chemicals and reagents glionic stimulation at 15 Hz for 45 min and then allowed to were obtained from Fisher Scientific (Montreal, Quebec, Canada). Experimentalprocedures. Anesthesia was induced in cats of either rest for 15 min. Conditioning of this nature has been previously sex (1.5-4.0 kg) with a 2: 1 mixture of NL0102 with 2% halothane and shown to increaseganglionic ACh stores (seeintroductory re- maintained with an intravenous injection of cr-chloralose (SO m&kg). marks) and the present experiments yielded similar results; the Superior cervical ganglia were prepared surgically for perfusion accord- ACh content of the conditioned ganglia was increasedby 588 ing to the method of Kibjakow (I 933) as described by Collier and Kwok (1982). All animal use procedures were in strict accordance with the -t 113 pmol (45 & 1l%, n = 7; p < 0.01) when compared to guidelines of the Medical Research Council of Canada and the Canadian the contralateral ganglia, which contained 1397 * 136 pmol Council on Animal Care and were approved by the local Animal Care (Fig. 1). When ganglia were conditioned and then rested with Committee. One or both ganglia were perfused (0.2-0.4 ml/min) with 10 WM dipyridamole present throughout the experiment, the a Krebs solution of the following composition (mM): NaCI, 120; KCl, increasein ACh content was 163 * 66 pmol (11 * 5%, n = 5; 4.6; CaCl,, 2.4; KH,PO,, 1.2; MgSO,, 1.2; NaHCO,, 25; and dextrose, 0.1 > p > 0.05) significantly lessthan in dipyridamole’s absence 10. Choline ch!oride (I 0 PM) was always added before perfusion. The medium was filtered and subsequently equilibrated with 5% CO, in O2 (p < 0.05, ANOVA/Newman-Keuls). In contrast, when 100 to maintain a pH of 7.4 at 37°C. In experiments that measured ACh FM NBTI was present, the amount of extra ACh contained was release, the perfusion medium also contained physostigmine sulfate (15 increasedto 1289 + 212 pmol (88 f IO%, n = 5; p < 0.01) PM); other drugs were used as described in the appropriate text. All drugs were added to the Krebs solution just before perfusion. After more than double the increaseproduced by conditioning alone the perfusion, ganglia were excised and placed in 1 ml of 10% trichlo- (p < 0.05, ANOVA/Newman-Keuls). roacetic acid (TCA) for 1 hr on ice. In an effort to shorten the period The two classesof transporters mentioned above exhibit ster- of rest following tetanic stimulation in some experiments, the ganglia eoselectivity with respectto the two stereoiso- were dissected from the distal end first so that preganglionic stimulation mers RO 1 l-3624 and meclonazepam (formerly called RO ll- could be maintained until placement into ice-cold TCA. The TCA was removed by extraction with ether and the aqueous layer was assayed 3 128). Both transporters are equally sensitive to RO 1 l-3624, for ACh content. but the NBTI-resistant carrier is 50-fold lesssensitive to me- Ganglia were stimulated via the preganglionic sympathetic trunk with clonazepam(Lee and Jarvis, 1988a).Thus, we testedthese agents The Journal of Neuroscience, August 1994, 14(8) 4929

No drug Dip NBTl 11-3624 Meclonaz Dfp N&l Figure 1. Effect of nucleoside transport inhibitors on the accumulation of rebound ACh. Ganglia were perfused with a Krebs solution (No drug) or one containing one or more of the following: dipyridamole (Dip; 10 FM), nitrobenzylthioinosine (NBTI; 100 PM), RO I l-3624 (11-3624; 100 PM), or meclonazepam (Meclonaz.: 100 *M). The ganglia were stimulated at 15 Hz for 45 min and then allowed to rest for 15 min. Barsrepresent ACh content (means f SEM of three to seven experiments) of stimulated ganglia as a percentage of the contralateral ganglion’s value (mean contralateral ACh content was 1450 f 57 pmol). *, p < 0.05, increased ACh content compared to contralateral control ganglion.

to determine iftheir effectswere similar to thoseofdipyridamole mitter releaseduring stimulation is necessaryfor the increased and NBTI reported above. When gangliawere conditioned and synthesis following conditioning (Collier et al., 1983). It has rested with 100 PM RO 11-3624 present throughout, the syn- been suggestedthat dipyridamole interacts with the glucose thesis of rebound ACh was 418 ? 39 pmol (30 +- 2% of the transporter, and although in earlier tests dipyridamole did not initial content), approximately 30% lessthan that produced by affect basal ACh synthesis in resting ganglia (Tandon and Col- conditioning in the absenceof drug. This change, however, rep- lier, 1993) it remained possiblethat dipyridamole might inhibit resenteda significant increasein ACh content compared to the ACh releaseor reduce ACh synthesis during stimulation and, contralateral ganglia (p < 0.05). In contrast to RO 11-3624, consequently, mask the appearanceof rebound ACh. exposure of ganglia to 100 KM meclonazepam throughout the To test the effect of dipyridamole on transmitter release,ACh experiment increasedthe accumulation of extra ACh to 1445 output was measuredfrom ganglia stimulated in the presence 5 301 pmol (102 + 15%, p < 0.01) significantly greater than of dipyridamole. In these experiments, ACh releasewas mea- that in the presenceof its stereoisomer(p < 0.01, ANOVA/ sured from both gangliaof each cat before, during, and after the Newman-Keuls) (Fig. 1). conditioning stimulation (45 min of 15 Hz stimulation preced- To test whether dipyridamole could prevent the extra ACh ing 15 min of rest); one ganglion was exposed to 10 PM dipyr- induced by NBTI, ganglia were stimulated and rested in the idamole during this time. Physostigmine (15 PM) was present presenceof both dipyridamole and NBTI. In three such exper- throughout the experiment to prevent the lossof secretedACh iments, the ACh content of conditioned ganglia was increased due to cholinesteraseactivity. As illustrated in Figure 2a, basal by only 2 19 k 96 pmol(14 + 6% compared to the contralateral ACh output before stimulation was similar betweenthe test and ACh content of 1493 f 113 pmol). This change was not sta- control ganglia(5.3 -t 0.7 vs 5.1 * 0.7 pmol/min, respectively). tistically significant (0.2 > p > 0.1) and was not different from Preganglionic stimulation clearly increasedACh releaseabove that observed in gangliaconditioned and rested in the presence the basaloutput from both ganglia. Dipyridamole did not inhibit of dipyridamole alone; it was clearly lessthan the changein the evoked ACh release; indeed, it appeared to augment initial presenceof NBTI alone (Fig. 1). transmitter output somewhat, but this difference did not reach statistical significance.The total evoked ACh output from di- Effect of dipyridamole on ACh releaseand ACh stores without pyridamole-treated ganglia(3266 +- 589 pmol) was not different conditioning from that releasedby the control ganglia (3006 + 220 pmol). Dipyridamole reduced the accumulation of rebound ACh in the Moreover, ACh efflux from both setsofganglia returned to basal tests above, just as it reduced the adenosine-inducedincrease values following the stimulation period. The transmitter re- in ACh synthesis(Tandon and Collier, 1993). Before concluding tained in theseganglia following the conditioning and rest was that this might indicate a role for endogenousadenosine in the also measured(Fig. 2b). These ACh levels were clearly greater formation of rebound ACh, it was necessaryto assessthe effects than the normal ACh content (compare to mean of 29 control of dipyridamole on ACh turnover during stimulation; trans- ganglia from experiments in the previous section: 1450 & 57 4930 Tandon and Collier - Adenosine Increases ACh Synthesis after Tetanic Activity a b 5000 15 Hz

0 control dipyridamole Time (min)

Figure 2. Effect of dipyridamole on ACh release. Both ganglia of each animal were perfused with a Krebs solution containing 15 FM physostigmine for 70 min; the test ganglion was also exposed to 10 PM dipyridamole. a, ACh release in the absence (0) or presence (0) of dipyridamole from ganglia rested for 10 min, stimulated for 45 min at 15 Hz (indicated by horizontal bar), and then allowed to rest for 15 min. b, ACh content of ganglia following the stimulation and rest periods. Results shown are the mean + SEM of 5 experiments. *, p c: 0.05. pmol), as was expected due to the presenceof physostigminein without physostigmine, the tissuesthat had been perfusedwith the perfusion buffer, which promotes the accumulation of “sur- dipyridamole contained some 30% lessACh than did those not plus ACh,” resulting in a doubling of the transmitter content exposed to that drug. Indeed, the amount of ACh (1097 + 320 (Birks and Macintosh, 196 1). However, as in the experiments pmol) by which the untreated and treated ganglia differed was greater in these experiments than it was in the ones without physostigmine (588 pmol), as if the presenceof physostigmine 1800 might increase the accumulation of rebound ACh. In other experiments, we tested the effect of dipyridamole on ACh synthesis during stimulation in the absenceof physostig- 1500 mine. Normally, the production of transmitter is augmented during neuronal activity to match ACh output such that tissue 1200 ACh storesare maintained relatively constant. We verified this in five experiments in which one ganglion of each cat was stim- ulated at 15 Hz for 45 min before its removal (stimulation of 900 the preganglionicnerve was maintained during excision ofthese ganglia so that the amount of time between the end of stimu- lation and placement in ice-cold TCA was minimal). The ACh 600 content of the stimulated ganglia was 1692 +- 129 pmol, com- parable to the 1707 * 182 pmol of the contralateral ganglia, d indicating that ACh synthesis indeed maintained ACh content 300 during stimulation. Since releasewas not affected by dipyrida- 2 mole, as shown above, any decreasedACh synthesiscaused by 0 h\\\\\u h\\.SSl the drug would be manifest as a decreasein ACh content at the Control Dip end of stimulation. Both ganglia of each cat were perfusedwith Krebs buffer while one ganglion was also exposed to 10 PM Figure 3. Effect of dipyridamole on ACh content following stimula- dipyridamole. The ganglia were stimulated for 45 min before tion. Pairs ofganglia were perfused with a Krebs solution and stimulated for 45 min at 15 Hz; one ganglion of each pair was also exposed to 10 being excised and assayedfor tissue ACh. In five such experi- PM dipyridamole. Bars represent mean f SEM of ACh content of five ments,the ACh content ofthe gangliastimulated in the presence experiments. of dipyridamole was 93 1 4% of the contralateral content, a The Journal of Neuroscience, August 1994, 74(E) 4931

180 c

Figure4. Effect of dipyridamole dur- ing stimulation or during rest. Ganglia were stimulated for 45 min at 15 Hz and then allowed to rest for 15 min. Dipyridamole was present either dur- ing the stimulation (n = 4) or during the rest period (n = 6). For comparison, the control (no drug)from Figure 1 is also shown. The bars represent ACh 100 content of the test ganglion expressed No drug Dip Dip as a percentage i SEM of that in the contralateral ganglion (mean contralat- during during era1 ACh content: 1349 -C 65 pmol). *, stimulation rest p < 0.05.

mean reduction of 106 ? 55 pmol. The difference did not reach statistical significance (0.2 > p > 0.1; Fig. 3). Thus, neither evoked ACh release nor ACh content was al- tered significantly during dipyridamole exposure, indicating that net ACh synthesis during prolonged stimulation is not affected 120 by the drug. Dipyridamole appears to inhibit specifically the posttetanic potentiation of ACh stores without compromising the ability of nerve terminals to maintain their normal stores. Ejkctiveness of dipyridamole to inhibit reboundACh accumulation during stimulation or rest To test whether the action of dipyridamole to inhibit the syn- thesis of rebound ACh requires its presence during the tetanic stimulation or during the period of rest following the stimula- tion, one ganglion of each cat was subjected to the conditioning as before, but instead of continuous exposure to dipyridamole throughout the experiment, the drug was present only for the 45 min stimulation period or for the subsequent 15 min rest period. Exposure to dipyridamole only during stimulation had no effect on the accumulation of rebound ACh; transmitter stores were increased by 613 -+ 133 pmol (45 + 8%, n = 4; p < 0.01) 20 compared to the contralateral ACh content (Fig. 4). However, in the presence of dipyridamole only during the rest period, only 344 & 133 pmol (24 k lo%, n = 6) of extra ACh was formed. This increase failed to be statistically significant in comparison to the ACh content of contralateral control ganglion (0.05 < p < 0.1). Thus, the dipyridamole-sensitive signal involved in stimulating the synthesis of rebound ACh appears to be manifest CHA (LLM) mainly following the tetanic stimulation, not during it. Figure5. Concentration-dependent effect ofcyclohexyladenosine(CHA) on ACh release. Ganglia were perfused with 15 PM physostigmine and Effkt of an adenosinereceptor antagonist on ACh release increasing concentrations of CHA during 5 Hz stimulation (r = 3). ACh during and following tetanic stimulation release is shown as a percentage * SEM of the control ACh release evoked by 5 Hz stimulation. Mean ACh output evoked by 5 Hz stim- The inhibitory effects of adenosine on neurotransmission are ulation in the presence of 0, 1, 10, and 100 PM CHA was 58 ?I 5, 55 well characterized and the present experiments confirmed this ? 6, 48 * 3, and 39 t 4 pmol/min, respectively. *, p < 0.05. 4932 Tandon and Collier - Adenosine Increases ACh Synthesis after Tetanic Activity

- 120 15 Hz ml-4E: B 100 \ ‘;3 B 80 PC - 80 Figure 6. Effect of cyclopentyltheo- li phylline(CPT) on ACh release.Pairs of gangliawere perfused with Krebsme- g 40 dium containing15 PM physostigmine; one ganglionof eachpair wasalso ex- posedto 100 FM CPT. Gangliawere 2 stimulatedat 15Hz for 45 min (hatched 20 bar), followedby 2 min of restto wash- out releasedACh, and then stimulated fG at 5 Hz (crosshatchedbar) for another 25 min.ACh releaseis shown from con- 2 0 trol (0) and CPT-exposed(W) ganglia 20 30 40 50 80 70 80 90 (meansf SEM of six experiments).*, p < 0.02. Time (min)

using cyclohexyladenosine (CHA) as the agonist. CHA de- ganglia, but from the control ganglia, it increasedprogressively creasedACh releaseevoked by 5 Hz stimulation in a concen- during the entire stimulation period. These resultsare suggestive tration-dependent manner (Fig. 5). of an inhibitory action of endogenousadenosine present just Thesedata, indicating that adenosinereceptor activation dur- following the end of the 15 Hz stimulation, and support the ing stimulation significantly lessensACh output measuredat 5 argument that adenosineis present in effective concentration Hz, suggesteda way to test whether adenosineis releasedfol- within the synaptic cleft following prolonged high-frequency lowing tetanic stimulation, aswas implied by the result of Figure stimulation. 4. The prediction was that if adenosineis releasedimmediately following the tetanic stimulation, its presencemight have an Potentiation of ACh releasefollowing conditioning inhibitory action on evoked ACh releaseduring this period due Previous studiessuggested that transmitter releaseis potentiated to an interaction with inhibitory adenosinereceptors. Cyclo- following the formation of rebound ACh, but the time course pentyltheophylline (CPT) was usedas the adenosineantagonist. of potentiation was somewhat equivocal; in one study, ACh Both ganglia of six cats were perfused with Krebs buffer con- releasefollowing the conditioning and rest protocol was poten- taining physostigmine (15 FM); one ganglion of each pair was tiated, but only after 2000 impulses had been delivered (Bour- perfusedwith medium that also contained 100 PM CPT. Both dois et al., 1974). On the other hand, Birks (1977) found that gangliawere stimulated at 15 Hz for 45 min, allowed to rest for ACh release was increased immediately upon stimulation in 2 min to allow for the washout of ACh releasedby the preceding proportion to the amount of extra ACh available. To examine stimuli, and then they were subjected to a test stimulation of 5 this issue,both ganglia of six cats were prepared for perfusion. Hz. The effluent was collected in successive5 min periods fol- One ganglion was perfused with Krebs medium for 45 min, lowing the onsetof each stimulation period. The pattern of ACh during which time it was conditioned with 15 Hz preganglionic output from theseexperiments is shown in Figure 6. The basal stimulation. The medium was then changed to one with phy- releasefrom gangliaperfused with CPT was similar to that from sostigmine (15 PM) and the ganglion was rested for 15 min, control ganglia, indicating that the drug alone did not promote before being stimulated with a 5 Hz test stimulation for another ACh release.The onset of 15 Hz stimulation was accompanied 45 min. The contralateral ganglion did not receive the condi- by rapid rise in ACh releasein the first collection, which sub- tioning stimulation, but was perfused with Krebs medium con- sequently stabilized at a lower output rate from both sets of taining physostigmine and subjected only to the test train of 5 ganglia; no difference in the pattern or the amount of ACh Hz stimulation for 45 min. ACh release was measuredfrom releasedWas evident whether CPT was present or not. Initiation both ganglia during the 5 Hz stimulation. As shown in Figure of the subsequent5 Hz test stimulation increasedACh release 7, basalACh releasewas similar whether or not the gangliahad from both sets of ganglia, expectedly lower than that observed been subjected to the conditioning stimulation. However, ACh in the first stimulaiion period becauseof the lower frequency output evoked by the 5 Hz test stimulation (i.e., total ACh used,and the ACh releasedfrom the CPT-treated ganglia was output minus basal ACh output) was greater from the condi- 40% greater(p < 0.02) during the first collection than that from tioned ganglia compared to the contralateral controls and re- the contralateral controls. ACh output in the subsequentcol- mained so for the duration of the simulation period. Overall, lections also tended to be greater but failed to be statistically the conditioned ganglia released44 + 15% (p < 0.05) more significant. The rate of releasewas stable from the drug-treated ACh than did their contralateral controls (Fig. 7, inset). The The Journal of Neuroscience,August 1994. 14(E) 4933

3000

3000

1000

0 Figure 7. Releaseof ACh from con- ditioned and control ganglia.The test gangliahad been conditioned for 45 min with 15 Hz stimulation,and then al- loweda 15 min restduring which time the mediumwas changed to one with physostigmine(15 FM). Following the rest, the gangliawere stimulatedat 5 Hz for 45 min and ACh releasefrom thesetissues is comparedto that from the contralateralganglia that had not beenconditioned. ACh releaseduring the 5 Hz test stimulationfrom the con- trol (0) and conditioned(m) ganglia is shownas means+ SEM of six experi- ments.Inset, Total evokedrelease from control (open bar) andconditioned (so!- id bar). Evoked releasewas calculated 0 10 20 30 40 50 asthe total ACh releaseminus the mean basaloutput estimated from measures Time (min) beforestimulation. amount of ACh remaining in theseganglia was measuredat the first 10 min and subsequently every 5 min for another 20 min. end of the experiment; the ACh content of the conditioned The conditioning did not affect basalACh releaseor the pattern ganglia was similar to that of their unconditioned counterparts of ACh releaseevoked by stimulation compared to the controls (2960 f 331 and 2710 ? 366 pmol, respectively), indicating (Fig. 8). Moreover, the amount of ACh releasedas a result of that the conditioned gangliado not retain their extra ACh during stimulation was unchanged by the conditioning (Fig. 8, inset). stimulation. Thus, initial ACh output is increasedin proportion Thus, the size of the readily releasablepool is not modified by to the increasein transmitter content, although toward the end the rebound ACh, and the increasedACh release(Fig. 7) pre- of the experiment this relationship doesnot hold, as the rate of sumably resultsfrom increasedmobilization of transmitter. ACh output remains high while ACh content returns to control levels. Discussion The role of endogenousadenosine in the accumulation of Relationship betweenrebound ACh and the readily releasable reboundACh compartment of ACh The present experiments were initiated in an attempt to test Preganglionic nerve stimulation in the presenceof vesamicol whether adenosineplays a role in an adaptive responseof cho- (formerly known as AH5 183), a vesicular ACh transport block- linergic nerve terminals that is caused by a period of condi- er, releasesonly approximately 14%of the total ACh storesthat tioning stimulation. The rebound phenomenon is fairly well is consideredto representthe readily releasablepool of ACh (as describedin the literature (seeintroductory remarks); it is man- definedby Birks and Macintosh, 1961) by virtue of its similarity ifest asan increasein ACh storesas a result ofincreased synthesis in both quantity and its temporal pattern of release(Collier et following prolongedtetanic activity. An increasein ACh content al., 1986). As shown above, rebound ACh is associatedwith a is evident in the presenceofadenosine also(Tandon and Collier, releasablepool following its synthesis, resulting in increased 1993), and thus, it appearedpossible that this purine, if endog- ACh output, but it is not known whether the size of the readily enously released,could mediate the synthesisof rebound ACh. releasablepool or the mobilization of ACh is altered as a con- We have shown previously that the adenosineeffect to in- sequenceof this extra ACh. creaseACh storeswas prevented by dipyridamole, an inhibitor To test this point, both gangliaof each cat were perfusedwith of nucleosidetransport. In the presentwork, dipyridamole clear- Krebs buffer for 1 hr. One ganglion of each pair was perfused ly reduced the accumulation of rebound ACh, supporting the at rest for this period, while the secondganglion wasconditioned notion that adenosinemight be involved in activating rebound with 45 min of 15 Hz stimulation followed by a 15 min rest. ACh synthesis. Dipyridamole’s reported ability to inhibit glu- The medium was then changedto one containing vesamicol(l0 cose transport (Deuticke et al., 1964) is unlikely to have been FM) and physostigmine (15 WM). Following another 10 min, a factor in this action becauseneither ACh synthesis nor ACh during which time the effluent was collected for measurement releasewas altered by dipyridamole during prolonged stimu- of basal ACh release,the sympathetic trunk was stimulated at lation. As both synthesis and release are highly sensitive to a rate of 5 Hz and the samplescollected every 2 min for the glucosedeprivation during neuronal activity and cannot be sus- 4934 Tandon and Collier - .,,enosiiieArl increases ACn Synthesis after Tetanic Activity

50

40

Figure 8. Effect of vesamicol on the release of rebound ACh. Both ganglia had been perfused with Krebs medium for 1 hr. One ganglion was stimulated 30 for 45 min at I5 Hz and then allowed a 15 min rest while the other ganglion was rested. The medium was changed to one containing vesamicol (I 0 PM) and physostigmine (I5 PM). Following an- 20 other IO min of rest, the preganglionic trunk was stimulated at 5 Hz and the ACh output was measured from the control (0) and conditioned (0) ganglia and is shown as means of six experi- ments. Error bars have been omitted for 10 clarity, and the variation (&SEM) is shown in the inset, which illustrates to- tal evoked ACh release from control (open bar) and conditioned (solid bar) ganglia in the presence of vesamicol. Evoked release was calculated as the total ACh release minus the mean basal 0 5 10 15 20 25 30 35 output estimated from measures before stimulation. Time (min)

tained for long periods without it (Kahlson and Macintosh, ing the test stimulation after high-frequency activity increased 1939) and dipyridamole is about IOO-fold more potent in its in the absence of CPT but did not in its presence (see Fig. 6) inhibition ofnucleoside transport compared to glucose transport possibly indicating that the time course or amount ofadenosine (Woffendin and Plagemann, 1987) the most plausible expla- release was somewhat variable between individual preparations. nation for dipyridamole’s action is its inhibition of adenosine A similar variability in evoked ACh discharge following a pro- uptake. Moreover, the ACh synthesis machinery was not im- longed high-frequency stimulation was reported by Birks (1977). paired, per se, by dipyridamole, and its inhibition of ACh syn- Overall, these pharmacological tests support the possibility thesis was limited to rebound ACh, suggesting a clear difference that adenosine acts as a signal to initiate the synthesis ofrebound in at least one of the mechanisms required for the activation of ACh after high-frequency stimulation. However, some of our synthesis during and following tetanic stimulation. results might not be entirely consistent with adenosine as the Dipyridamole’s inability to prevent the appearance of the only mediator of this phenomenon. First, dipyridamole present extra ACh when it was present only during the stimulation following the stimulation was only partly effective, perhaps be- period further eliminates the possibility that dipyridamole in- cause its access to its target was delayed when the perfusion terfered with evoked ACh release or ACh synthesis during stim- medium was changed following tetanic stimulation, but possibly ulation. It was, however, partly effective if present only in the indicating that adenosine was only partly responsible. Second, rest period following stimulation, suggesting that, if adenosine RO 1 l-3624, an agent pharmacologically similar to dipyrida- is responsible for rebound ACh, its appearance and action fol- mole in its ability to block both the NBTI-sensitive and -resis- lows the period of stimulation rather than during it. tant carriers with equivalent potency (Lee and Jarvis, 1988a), This notion of a poststimulation appearance of adenosine is only partly inhibited the accumulation of rebound ACh, al- compatible with results obtained in the experiments measuring though in previous tests, the same concentration as used here ACh release in the presence and absence of an adenosine an- was as effective as dipyridamole to decrease the adenosine effect. tagonist. This test exploited the -mediated This also could indicate a role for some mediator other than suppression of transmitter release that occurs in a variety of adenosine; however, it must be kept in mind that the efficacy preparations (see review by White, 1988) including the sym- of this compound to block completely movement of adenosine pathetic ganglion, as evidenced by the present result showing through the NBTI-resistant transporters has not been properly 33% inhibition of evoked ACh release by CHA. Blockade of studied. Shank‘and Baldy (1990) have reported that at least two, these receptors by CPT revealed a 40% increase in the rate of possibly three, NBTI-resistant nucleoside transport systems can ACh release evoked by test stimulation following tetanic con- be distinguished in synaptosomes prepared from rat or guinea ditioning, as if endogenous adenosine present at such time was pig cerebral cortex, and the possibility that inhibition by RO inhibitory to ACh release in the absence of CPT. This increased 11-3624 is incomplete in one or more of these systems cannot output coincided with both the activation of rebound ACh syn- be excluded. thesis and the dipyridamole-sensitive stage. It is also notable An interesting feature of the present results from the exper- that the variability in ACh output from successive samples dur- iments that tested the effect of NBTI or of meclonazepam was The Journal of Neuroscience, August 1994, 14(8) 4935 their ability to increase considerably the amount of rebound involvement of retrograde transmission in activity-induced syn- ACh formed. It is possible that this effect is unrelated to their aptic plasticity (see review by Jesse11 and Kandel, 1993). ability to inhibit nucleoside uptake. However, considering that This notion leads to the question of what signals adenosine these two drugs are structurally quite different and that their release if it is to act as a retrograde transmitter. The role of only known similarity is their inhibition of the NBTI-sensitive ACh, the principal neurotransmitter, as this signal is unlikely. nucleoside transporter, it might be that their effect to increase First, neither muscarinic (Bourdois et al., 1974) nor nicotinic rebound ACh is based on this characteristic. If so, the result (Collier et al., 1983) receptor activation appears to be obligatory suggests that blockade ofthe NBTI-sensitive transporters shunts for the formation of rebound ACh. Second, the rate of ACh adenosine toward the NBTI-resistant sites and, in this way, output evoked by 16 Hz stimulation is not different from that provides more adenosine to whatever mechanism is responsible at 64 Hz (Birks and Macintosh, 1961) yet the synthesis of for its ability to increase ACh synthesis. The present result show- rebound ACh is clearly frequency dependent (Bourdois et al., ing dipyridamole to block the NBTI-induced increase of re- 1974; Birks, 1977). Alternate transmitters, such as the peptides bound ACh is compatible with this notion. There are two in- present in synaptic boutons of sympathetic ganglia (for review, teresting corollaries to this: first, the endogenous adenosine see Elfvin et al., 1993) may be more likely candidates, especially available to the preganglionic nerve terminals for transport by when it is considered that high-frequency stimulation is gen- the NBTI-resistant carriers must be subsaturating; second, the erally a prerequisite for peptide release (for reviews, see Bartfai two types of nucleoside transporters must be in close enough et al., 1988; Kupfermann, 1991) just as it is for the initiation apposition to each other for the postulated shunting ofadenosine of the rebound phenomenon. to be functional. With respect to the last point, the two types Overall, these results support a role for endogenous adenosine af nucleoside transporters are considered to coexist on certain acting as a signal to activate the synthesis of rebound ACh; cell types (Belt, 1983ab; Plagemann and Wohlheuter, 1985) whether it is the only potentiating factor involved in the post- including neurons (Lee and Jarvis, 1988ab; Shank and Baldy, tetanic phenomenon is not clear. 1990; Jones and Hammond, 1992). If this coexistence were to be so for the preganglionic nerve endings, it implies that the Compartmentalization and release of rebound ACh intracellular accumulation of adenosine that increases ACh syn- Kinetic analysis oftransmitter output from ganglia suggests that thesis would have to be restricted to a site close to the NBTI- the ACh release behaves as if it is stored in at least two com- resistant carriers; otherwise, transport through the NBTI-sen- partments: a smaller readily releasable pool, and a larger reserve sitive transporters would be expected to have the same effect, pool (Birks and Macintosh, 196 1). The compartmentalization as it is unlikely that any intracellular process could distinguish of rebound ACh in this scheme has remained somewhat am- adenosine on the basis of its site of entry. Thus, it seems more biguous. Bourdois et al. (1974) suggested that the rebound ACh likely that the NBTI-sensitive uptake is not associated with incorporated into the reserve pool because conditioned ganglia preganglionic nerve endings but on structures close enough to exhibited an increased output of ACh only after a significant lag them to affect the synaptic concentration of adenosine. Fur- period. However, Birks (1977) reported that evoked release fol- thermore, the presence of adenosine transporters not linked to lowing the synthesis of the extra ACh was proportional to the the synthesis of rebound ACh may represent potential targets increase in total transmitter stores. Furthermore, Collier et al. for regulatory mechanisms to determine synaptic adenosine (1983) radiolabeled rebound ACh by presenting conditioned concentration, and thus, govern the extent of potentiation of ganglia with ?H-choline during the rest period; when ACh release transmitter stores depending upon the strength and duration of was evoked by subsequent preganglionic stimulation, the spe- the conditioning stimulation. cific activity of the released ACh matched that of the tissue We have previously speculated that one possible source of ACh, indicating that rebound ACh had mixed with preexisting synaptic adenosine in the ganglia could be from ATP co-stored stores prior to its discharge. with ACh in synaptic vesicles (Tandon and Collier, 1993). How- We extended these studies by measuring evoked ACh release ever, the results discussed above suggest that adenosine efflux following conditioning in the absence or presence of vesamicol, in the present study likely occurred after, not during, the con- a drug that prevents the accumulation of ACh by vesicles (for ditioning stimulation, that is, when ACh output had returned review, see Parsons et al., 1993) and allows the release of only to basal levels. Thus, the endogenous synaptic adenosine does about 14% of the total ganglionic ACh stores upon stimulation, not appear to originate from vesicular stores co-released with a fraction that is considered to represent the readily releasable ACh. Doubtless, there are other mechanisms that might allow pool of transmitter (Collier et al., 1986; Cabeza and Collier, adenosine into the synaptic cleft that can be considered, in- 1988; Prado et al., 1992). In the absence of vesamicol, the initial cluding the nucleoside transporters themselves, which are able ACh output from conditioned ganglia was increased in propor- to operate in reverse direction (see review by Geiger and Nagy, tion to the amount of rebound ACh accumulated. However, 1990). However, the simplest interpretation of our previous ACh release remained potentiated for the duration of stimula- results with exogenous adenosine application suggests that aden- tion, whereas the ACh stores had returned to control levels by osine uptake into nerve terminals preceded activation of ACh the end ofstimulation. Therefore, while rebound ACh may have synthesis, so it would be unlikely that, in the context of the been the source of ACh initially, some other mechanism main- present experiments, the same presynaptic sites that import tained release at an elevated level. It is not clear whether this adenosine are involved first with its export into the synapse. longer-lasting potentiation of release is related to an effect of Thus, a postsynaptic source of adenosine appears to be more adenosine or to some other simultaneously occurring process. likely and there is evidence for this in other systems (Wolinsky For instance, it may be related to a similar phenomenon ob- and Patterson, 1985) as well as sympathetic ganglia (Rubio et served by Briggs et al. (1985) after a short tetanus, which did al., 1988). Adenosine might act as a diffusible retrograde signal not require increased transmitter content. Alternatively, aden- to accelerate ACh synthesis; there is appreciable interest in the osine has been reported to induce a persistent increase in glu- 4936 Tandon and Collier * Adenosine Increases ACh Synthesis after Tetanic Activity

tamate release from hippocampal slices, an action that is not by extraction with sodium tetraphenylboron in orgaruc solvents. Bio- mimicked by A, or AZ receptor agonists(Nishimura et al., 1990, them J 113:291-298. Friesen AJD, Khatter JC (197 1) The effect ofpreganglionic stimulation 1992; Okada et al., 1992); it is possiblethat a similar effect of on the acetylcholine and choline content of a sympathetic ganglion. adenosineis apparent in gangliafollowing the conditioning par- Can J Phvsiol Pharmacol49:375-38 1. adigm of the present experiments. Geiger JD,- Nagy JI (1990) Adenosine deaminase and [ZH]nitro- In thk presenceof vesamicol, conditioned gangliareleased the benzylthioinosine as markers of adenosine metabolism and transport in central purinergic systems. In: Adenosine and adenosine receptors sameamount ofACh as their unconditioned controls, suggesting (Williams M, ed), pp 225-288. Clifton, NJ: Humana. that the less readily releasable compartment adapts to incor- Goldberg AM, McCaman RE (1973) The determination of picomole porate the extra ACh and the size of the readily releasable com- amounts of acetylcholine in mammalian brain. J Neurochem 20: l-8. partment remains the same. The increased rate of ACh output Jesse11TM, Kandel ER (1993) Synaptic transmission: a bidirectional from conditioned ganglia in the absence of vesamicol is pre- and self-modifiable form ofcell+elI communication. Cell 72/Neuron lO:l-30. sumably the result of an increased rate of mobilization from the Jones KW, Hammond JR (1992) Heterogeneity of [‘Hldipyridamole less readily releasable pool. As rebound ACh mixes with the binding to CNS membranes: correlation with [‘Hlnitroben- preexisting stores (Collier et al., 1983), it would appear that, zylthioinosine binding and [‘Hluridine influx studies. J Neurochem although only the size of the reserve pool is modified, rebound 59:1363-1371. Kahlson G, Macintosh FC (1939) Acetylcholine synthesis in a sym- ACh takes part in the tonic exchange of ACh molecules between pathetic ganglion. J Physiol (Lond) 961277-292. the reserve and readily releasable compartments. Similarly, our Kibjakow AW (1933) Uber humorale Ubertrazung der Erregung von results using exogenous adenosine suggested also that the extra einem Neuron auf das andere. Pfluegers Arch Physiol 232:432-443. ACh synthesized in adenosine’s presence was incorporated into, Kupfermann I (199 1) Functional studies of cotransmission. Physiol and increased release from, the ACh pool that requires mobi- Rev 71:683-732. Lee CW, Jarvis SM (1988a) Kinetic and inhibitor specificity of aden- lization for release (Tandon and Collier, 1993). osine transport in guinea pig cerebral cortical synaptosomes: evidence for two nucleoside transporters. Neurochem Int 12:483+92. References Lee CW, Jarvis SM (1988b) Nucleoside transport in rat cerebral cor- tical synaptosomes. Evidence for two types of nucleoside transporters. Bartfai T, Iverfeldt K, Fisone G, Serfozo P (1988) Regulation of the Biochem J 249:557-564. release ofcoexisting neurotransmitters. Annu Rev Pharmacol Toxic01 Nishimura S, Mohri M, Okada Y, Mori Y (1990) Excitatory and 28:285-3 10. inhibitory effects of adenosine on the neurotransmission in the hip- Belt JA (1983a) Heterogeneity of nucleoside transport in mammalian pocampal slices of guinea pig. Brain Res. 525: 165-I 69. ceils. Two types of transport activity in L12 10 and other cultured Nishimura S, Okada Y, Amatsu M (1992) Post-inhibitory excitation neoplastic cells. Mol Pharmacol 24:479-484. of adenosine on neurotransmission in guinea pig hippocampal slices. Belt JA (1983b) Nitrobenzylthioinosine-insensitive transport Neurosci Lett 139: 126-l 29. in human lymphoblastoid and murine leukemia cells. Biochem Bio- Okada Y, Sakurai T, Mori M (1992) Excitatory effect of adenosine on phys Res Commun 1 10:4 17-423. neurotransmission is due to increase of transmitter release in the Birks RI (1977) A long-lasting potentiation of transmitter release re- hippocampal slices. Neurosci Lett 142:233-236. lated to an increase in transmitter stores in a sympathetic ganglion. O’Regan S, Collier B (198 1) Factors affecting choline transport by the J Physiol (Lond) 271:847-862. cat superior cervical ganglion during and following stimulation, and Birks RI (1978) Regulation by patterned preganglionic neural activity the relationship between choline uptake and acetylcholine synthesis. of transmitter stores in a sympathetic ganglion. J Physiol (Lond) 280: Neuroscience 6:5 1 I-520. 559-572. Parsons SM, Prior C, Marshall IG (1993) Acetylcholine transport, Birks RI, Fitch SJG (1974) Storage and release of acetylcholine in a storage and release. Int Rev Neurobiol 35:279-390. sympathetic ganglion. J Physiol (Lond) 240: 125-I 34. Plagemann PGW, Wohlheuter RM (1985) Nitrobenzylthioinosine- Birks RI, Ma&nosh FC (196 1) Acetylcholine metabolism of a sym- sensitive and -resistant nucleoside transport in normal and trans- nathetic aannlion. Can J Biochem Phvsiol 39:787-827. formed cells. Biochim Biophys Acta 8 16:387-395. Bdurdois I%, McCandless DL, MacIniosh FC (1974) A prolonged Prado MAM, Gomez MV, Collier B (1992) Mobilization of the readily after-effect of intense synaptic activity on acetylcholine in a sympa- releasable pool of acetylcholine from a sympathetic ganglion by ti- thetic ganglion. Can J Physiol Pharmacol 53: 155-165. tyustoxin in the presence of vesamicol. J Neurochem 59:544-552. Briggs CA, McAfee DA, McCaman RE (1985) Long-term potentiation Rosenblueth A, Lissak K, Lanari A (1939) An explanation of the five of synaptic acetylcholine release in the superior cervical ganglion of stages of neuromuscular and ganglionic synaptic transmission. Am J the rat.~J Physiol (Lond) 363: 18 l-1 90. Physiol 128:3 144. Cabeza R, Collier B (1988) Acetylcholine mobilization in a sympa- Rubio R, Bencherif M, Berne RM (1988) Release of purines from thetic ganglion in the presence and absence of 2-(4-phenylpiperidi- postsynaptic structures of amphibian ganglia. J Neurochem 5 1: 17 17- no)cyclohexanol (AH5 183). J Neurochem 50: 112-l 2 1. 1723. Collier B, Kwok YN (1982) Superior cervical ganglion:- - chemical con- Shank RP, Baldy WJ (1990) Adenosine transport by rat and guinea siderations. In: Progress ‘in cholinergic biology: model cholinergic pig synaptosomes: basis for differential sensitivity to nucleoside trans- synapses (Hanin I, Goldberg, AM, eds), pp 169-190. New York: porters. J Neurochem 55:541-550. Raven. Tandon A, Collier B (199 1) A possible role for endogenous adenosine Collier B, Kwok YN, Welner SA (1983) Increased acetylcholine syn- at sympathetic ganglia. J Neurochem [Suppl] 57:S155A. thesis and release following presynaptic activity in a sympathetic Tandon A. Collier B (1993) Increased acetvlcholine content induced ganglion. J Neurochem 40:9 l-98. by adenosine in a sympathetic ganglion and its subsequent mobili- Collier B, Welner SA, RiEny J, Araujo DM (1986) Acetylcholine syn- zation by electrical stimu1ation.J Neurochem 60:2 12412 133. thesis and release by a sympathetic ganglion in the presence of 2-(4- Welner SA. Collier B (1984) Uotake. metabolism and releasabilitv of phenylpiperidino)cyclohexanol (AH5183). J Neurochem 46:822-830. ethyl analogues of hdmocholine by rat brain. J Neurochem 43: 1143- Deuticke B. Duhm J. Gerlach E (1964) Beeinflussuna der monosac- 1151. charid-permeabilitlt des menschen-erythrocyten durch eine pyrimi- White TD (1988) Role of compounds in autonomic neuro- do-pyrimidin-verbindung. Pfluegers Arch 280:275-280. transmission. Pharmacol Ther 38:129-168. Elfvin L-G, Lindh B, Hijkfelt T (1993) The chemical neuroanatomy Woffendin C, Plagemann PGW (1987) Interaction of [JH]dipyridamole of sympathetic ganglia. Annu Rev Neurosci 16:47 l-507. with the nucleoside transporters of human erythrocytes and cultured Feldberg W (1943) Synthesis of acetylcholine in sympathetic ganglia animal cells. J Membr Biol 98:89-100. and cholinergic nerves. J Physiol (Lond) 10 1:432-445. Wolinsky EJ, Patterson PH (1985) Potassium-stimulated purine re- Fonnum F (1969) Isolation of choline esters from aqueous solution lease by cultured sympathetic neurons. J Neurosci 5:1680-1687.